Skip to main content
2025 CNSF Congress Main banner
Final Program


Calendar-of-Events
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Steven Vernino, MD, PhD

Steven Vernino, MD, PhD is Professor and Vice Chair of Neurology at UT Southwestern Medical Center. He is director of the autonomic disorders program and the multidisciplinary clinical center of excellence for multiple system atrophy clinic. He holds the Dr. Bob and Jean Smith Foundation Distinguished Chair in Neuromuscular Disease Research and the Rex Griswold Distinguished Professorship in Multiple System Atrophy

Dr. Vernino earned his MD and PhD in Neuroscience at Baylor College of Medicine. He completed neurology residency and fellowship training in neuroimmunology and EMG at Mayo Clinic in Rochester, MN. He is Board Certified in Neurology, Neuromuscular Medicine, and Autonomic Disorders. He has served as president of the American Autonomic Society and the medical advisory boards of the Myasthenia Gravis Foundation, The MSA Coalition, Encephalitis 411 and Dysautonomia International. He is a Fellow of the American Academy of Neurology (AAN), American Neurological Association and American Autonomic Society. Dr. Vernino has been recognized as an outstanding clinician, researcher and teacher with numerous awards. He was recipient of the 1998 AAN Founders Award, 2013 AAN program director award, 2016 Regents Outstanding Teacher Award from the University of Texas system, and 2024 Irwin Schatz Award for Autonomic Disorders from the AAN. He is a past president of the American Autonomic Society.

Dr. Vernino has published over 180 peer-reviewed articles as well as dozens of book chapters. His main research interest has been in treatment of autonomic disorders and in helping to establish the field of autoimmune neurology. Most notably, he identified the presence of antibodies to ganglionic acetylcholine receptors as the cause of a rare disorder of the autonomic nervous system, autoimmune autonomic ganglionopathy (AAG), as well as characterizing several neurological antibodies related to paraneoplastic disorders. He established a multidisciplinary care model for multiple system atrophy (MSA) at UT Southwestern leading to the designation of MSA centers of excellence by Mission MSA. Dr. Vernino has been involved in numerous collaborative and investigator-initiated clinical trials. He was the co-chair of an NIH workshop on defining priorities for POTS research, and he was recently awarded an NIH R01 grant to better define the clinical features of POTS.

Presentation(s):